Bank of America Corp DE Buys 991,620 Shares of Sotera Health Company $SHC

Bank of America Corp DE lifted its stake in shares of Sotera Health Company (NASDAQ:SHC - Free Report) by 332.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,289,649 shares of the company's stock after buying an additional 991,620 shares during the period. Bank of America Corp DE owned about 0.45% of Sotera Health worth $18,494,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of SHC. IFP Advisors Inc grew its holdings in shares of Sotera Health by 1,105.6% during the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company's stock worth $26,000 after purchasing an additional 1,371 shares during the last quarter. Rothschild Investment LLC bought a new position in shares of Sotera Health during the fourth quarter valued at $27,000. Root Financial Partners LLC raised its stake in shares of Sotera Health by 217.5% during the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company's stock valued at $30,000 after acquiring an additional 1,455 shares during the last quarter. Eurizon Capital SGR S.p.A. acquired a new position in shares of Sotera Health during the fourth quarter worth $40,000. Finally, Allworth Financial LP lifted its holdings in shares of Sotera Health by 922.0% during the fourth quarter. Allworth Financial LP now owns 3,025 shares of the company's stock worth $53,000 after purchasing an additional 2,729 shares during the period. 91.03% of the stock is currently owned by institutional investors.

Insider Transactions at Sotera Health

In other news, insider Michael P. Rutz sold 150,000 shares of the firm's stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $18.84, for a total value of $2,826,000.00. Following the completion of the sale, the insider directly owned 334,279 shares in the company, valued at $6,297,816.36. This trade represents a 30.97% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the business's stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the completion of the sale, the chairman directly owned 3,969,393 shares of the company's stock, valued at $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 1,294,515 shares of company stock worth $23,999,528 in the last three months. Insiders own 15.36% of the company's stock.

Sotera Health Stock Performance

Shares of SHC stock opened at $19.00 on Thursday. The firm has a 50 day moving average of $17.64 and a 200-day moving average of $16.33. The company has a market cap of $5.42 billion, a price-to-earnings ratio of 33.33 and a beta of 1.77. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33. Sotera Health Company has a 52 week low of $13.09 and a 52 week high of $19.85.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.24 by $0.02. The company had revenue of $321.38 million for the quarter, compared to the consensus estimate of $309.70 million. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. Sotera Health's quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.20 EPS. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, equities analysts forecast that Sotera Health Company will post 0.86 earnings per share for the current year.

Wall Street Analysts Forecast Growth

SHC has been the topic of a number of analyst reports. The Goldman Sachs Group assumed coverage on Sotera Health in a research report on Friday, June 5th. They issued a "buy" rating and a $20.00 price target on the stock. Weiss Ratings upgraded Sotera Health from a "hold (c)" rating to a "hold (c+)" rating in a research report on Tuesday, August 11th. JPMorgan Chase & Co. lifted their price objective on Sotera Health from $16.00 to $18.00 and gave the stock a "neutral" rating in a research note on Friday, August 7th. Barclays increased their target price on shares of Sotera Health from $19.00 to $22.00 and gave the company an "overweight" rating in a research report on Friday, August 7th. Finally, UBS Group set a $19.00 price target on shares of Sotera Health in a report on Wednesday, June 24th. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $21.50.

About Sotera Health

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source